Acral Melanoma
📧 Sign up to get email alerts when something new happens for Acral Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma [Phase 2]
A Phase 2 neoadjuvant trial is evaluating pucotenlimab with lenvatinib and temozolomide for resectable acral melanoma (Stage IIB/III); the s…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma [Phase 2]
Phase 2 clinical trial evaluating a combination including iparomlimab and tuvoraleimab with bevacizumab, nab-paclitaxel, and carboplatin as …
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial [Phase 2]
Phase 2 trial evaluating time-of-day specified immunotherapy for advanced melanoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial [Phase 2]
A Phase II trial evaluating perioperative toripalimab and endostatin for stage II melanoma is currently recruiting, sponsored by Fudan Unive…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy [Phase 2]
Phase 2 study evaluating IBI363 monotherapy versus pembrolizumab for unresectable locally advanced or metastatic mucosal or acral melanoma i…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor [Phase 2]
A Phase 2 trial evaluating the combination of Vactosertib and Pembrolizumab in acral and mucosal melanoma patients who progressed on prior i…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma [Phase 2]
This clinical trial update describes a Phase 2 neoadjuvant study of camrelizumab plus apatinib and temozolomide in high-risk acral melanoma …
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions.
This observational study evaluates the LumAssure device in participants undergoing assessment of various skin conditions (including basal ce…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma [Phase 3]
Phase 3 trial investigating camrelizumab plus apatinib and temozolomide as first-line therapy for advanced acral melanoma is currently recru…
-
CLINICAL_TRIALS trial_result · 2023-03-09Clinical Trial Update: The Study of IBI310 in Combination With IBI308 Compared to High-Dose Interferon In Patients With Acral Melanoma That Has Been Removed by Surgery [Phase 3]
Phase 3 trial evaluating IBI310 in combination with IBI308 versus high-dose interferon in acral melanoma that has been removed by surgery; s…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma [Phase 2]
Phase 2 trial evaluating nilotinib in patients with metastatic mucosal, acral, or chronically sun-damaged melanoma who are resistant or into…